The authors performed a network meta-analysis that compared high-intensity laser therapy (HILT), low-level laser therapy (LLLT), and conventional physical therapy (CPT) for patients with subacromial impingement syndrome (SIS). They screened eight databases for randomized controlled trials and ultimately included 19 studies representing 989 participants. The selected trials were randomized controlled trials; the abstract reports the trial count and pooled participant total but does not list individual trial designs or sample-size details in the abstract text. The primary endpoints for pooled analysis were pain, measured by the visual analogue scale (VAS), and shoulder function, measured by the Shoulder Pain and Disability Index (SPADI). The study team declared no competing interests.
Data indicated that both HILT combined with CPT and LLLT combined with CPT produced greater reductions in VAS pain scores compared with CPT alone. The investigators reported low to moderate certainty for those pain outcomes. The report also stated that when HILT + CPT was compared directly with LLLT + CPT, no difference in pain relief was detected. Short, clear point: both laser-assisted strategies reduced pain versus conventional therapy in the pooled RCT data. Longer detail: the evidence synthesis suggested similar analgesic effects between the two laser modalities, with neither modality proving superior in head-to-head network comparisons according to the abstract.
The pooled evidence for shoulder function, as measured by SPADI, yielded a different signal. Authors noted that very low to low quality evidence indicated no significant improvement in SPADI scores when either HILT + CPT or LLLT + CPT was compared with CPT alone. The study team observed no difference in functional effect between HILT + CPT and LLLT + CPT. In practice, then, the analyzed trials showed pain reduction without a corresponding, detectable improvement in the aggregated shoulder function measure across the included RCTs. The abstract does not provide subgroup analyses, timepoints of assessment, or absolute SPADI values; those methodological specifics were not reported in the abstract text.
The authors rated the certainty of evidence differently for the two primary outcomes. Pain outcomes (VAS) were supported by evidence of low to moderate certainty. Function outcomes (SPADI) were supported by very low to low quality evidence. Short sentence: confidence in pain findings is limited. Longer clause: these graded certainty statements reflect the study team's assessment of trial quality, consistency, and directness across the 19 included RCTs as summarized in the abstract. The network meta-analysis format allowed indirect and direct comparisons, but the abstract does not present detailed risk-of-bias domains, inconsistency metrics, or GRADE tables; the source abstract did not report those technical items.
The authors concluded that current evidence shows no difference between HILT + CPT and LLLT + CPT in relieving pain for SIS, and that both laser approaches may reduce pain relative to CPT. They also concluded that no improvement in shoulder function was found in the pooled SPADI analyses. The abstract signals several limitations: evidence quality was graded low to very low across key outcomes, and the pooled results did not resolve whether laser treatment improves functional recovery. The abstract did not report laser parameters (for example, dose, wavelength, energy density, session frequency, or duration), so optimal dosing and treatment protocols remain unspecified in the abstract. The report did not provide detailed subgroup or timepoint data within the abstract text; those specifics were not reported there.
Open clinical questions remain. Which patient subgroups (severity, chronicity, or structural pathology) — if any — derive meaningful functional benefit from laser therapy? What are the optimal HILT and LLLT dosing parameters to maximize analgesia while producing functional gains? How durable are the pain reductions beyond trial follow-up periods reported across the pooled studies? These clinical uncertainties are directly reflected in the authors' graded-certainty statements and the description of low-to-very-low quality evidence.
The abstract ended with declarations that ethics approval and consent to participate were not applicable and that the authors reported no competing interests. The final, concrete takeaway from the abstract: evidence supports modest pain reduction when HILT or LLLT is added to conventional physical therapy, but the current RCT evidence base — as summarized by the authors — does not demonstrate improved shoulder function and is limited in certainty. The abstract did not include detailed trial-level parameters or dosing regimens, nor did it present GRADE tables or full risk-of-bias assessments in the abstract text. Next steps documented implicitly in the limitations are focused: higher-quality, adequately powered RCTs with standardized reporting of laser parameters and functional endpoints are needed to answer the unresolved clinical questions.